Cancer Immunology Research
Scope & Guideline
Transforming Research into Cancer Solutions
Introduction
Aims and Scopes
- Cancer Immunotherapy Mechanisms:
The journal extensively covers the mechanisms of various cancer immunotherapies, including checkpoint inhibitors, CAR T-cell therapies, and immune-modulating agents, highlighting their biological underpinnings and clinical implications. - Tumor Microenvironment Dynamics:
Research frequently addresses the role of the tumor microenvironment in modulating immune responses, including studies on immune cell infiltration, metabolic reprogramming, and interactions between tumor and immune cells. - Translational Research and Clinical Applications:
Cancer Immunology Research bridges basic research and clinical applications, providing insights into how laboratory findings can be translated into effective treatments, including novel vaccine strategies and combination therapies. - Genomic and Proteomic Insights:
The journal publishes studies that leverage genomic and proteomic technologies to identify biomarkers and therapeutic targets, enhancing personalized medicine approaches in cancer treatment. - Emerging Technologies in Immunotherapy:
There is a strong emphasis on innovative technologies, such as CRISPR gene editing, single-cell sequencing, and machine learning applications, aimed at improving the efficacy and safety of cancer immunotherapies.
Trending and Emerging
- Combination Immunotherapy Approaches:
There is an increasing focus on combination therapies that integrate various immunotherapeutic strategies, such as combining checkpoint inhibitors with CAR T-cell therapy or other immune modulators, to enhance overall treatment efficacy. - Microbiome and Immunotherapy Interactions:
Recent studies are exploring the role of the gut microbiome in modulating immune responses to cancer therapy, revealing how microbial communities can influence treatment outcomes and immune system dynamics. - Personalized Cancer Vaccines:
The development of personalized cancer vaccines based on individual tumor neoantigens is gaining prominence, emphasizing tailored approaches to immunotherapy that leverage specific patient tumor profiles. - Role of Metabolism in Immune Function:
Research increasingly focuses on the metabolic pathways of immune cells in the tumor microenvironment, exploring how metabolic reprogramming can enhance or inhibit anti-tumor immunity. - Single-Cell and Spatial Transcriptomics:
The application of single-cell RNA sequencing and spatial transcriptomics is becoming more prevalent, providing deeper insights into the cellular composition and functional states of immune cells in tumors, which is crucial for understanding resistance mechanisms.
Declining or Waning
- Traditional Chemotherapy Studies:
Research focusing on traditional chemotherapy alone, without immunological context, appears to be decreasing, as the field shifts towards understanding how to synergize chemotherapy with immunotherapy. - Basic Descriptive Studies on Tumor Cells:
There has been a noticeable reduction in purely descriptive studies regarding tumor cell biology, with a greater emphasis now placed on functional studies that explore the tumor-immune interaction. - Standalone Immunomodulatory Agents:
The focus on isolated immunomodulatory agents, without combination strategies or contextual understanding of their mechanisms, is less prevalent, indicating a trend towards integrated approaches in immunotherapy. - General Immune Response Studies:
Research that broadly addresses immune responses without specific relevance to cancer immunology or therapy is becoming less common, as the journal favors studies with direct implications for cancer treatment.
Similar Journals
INTERNATIONAL JOURNAL OF ONCOLOGY
Advancing cancer research for a healthier tomorrow.INTERNATIONAL JOURNAL OF ONCOLOGY is a leading academic publication dedicated to advancing the field of cancer research and treatment. Published by SPANDIDOS PUBL LTD in Greece, this journal, with ISSN 1019-6439 and E-ISSN 1791-2423, has established itself as a reputable source of peer-reviewed articles since its inception in 1993. With an impressive Q2 ranking in both Cancer Research and Oncology categories, as well as high Scopus ranks reflecting its significant contribution to the fields of Medicine and Biochemistry, the journal offers a platform for researchers, clinicians, and students alike to disseminate their findings and engage in dialogue surrounding innovative practices and breakthroughs. Although the journal follows a traditional subscription model, it continues to attract a diverse readership interested in the latest developments in oncological research, providing essential insights into cancer biology, therapeutics, and patient care. With a commitment to excellence, the INTERNATIONAL JOURNAL OF ONCOLOGY plays a vital role in shaping the future of oncology research and is a must-read for anyone passionate about advancing cancer treatment and prevention.
ImmunoTargets and Therapy
Unlocking the Future of Immune HealthImmunoTargets and Therapy is a leading open access journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing the field of immunology and its various therapeutic applications. Since its inception in 2012, the journal has rapidly become a vital resource for researchers, professionals, and students, achieving notable recognition with a Q1 ranking in both Immunology and Immunology and Allergy categories as of 2023. With an impressive Scopus ranking of #22 out of 233 in Medicine - Immunology and Allergy, and #25 out of 236 in Immunology and Microbiology, this journal maintains a 90th percentile standing in its field. ImmunoTargets and Therapy not only publishes original research articles, reviews, and clinical studies, but also fosters an inclusive platform for the dissemination of innovative findings critical to the fight against immunological disorders. Based in New Zealand, it serves a global audience, promoting knowledge exchange and collaboration through its open access model.
CRITICAL REVIEWS IN IMMUNOLOGY
Fostering Critical Conversations in ImmunologyCRITICAL REVIEWS IN IMMUNOLOGY, published by BEGELL HOUSE INC, is an essential journal in the field of immunology that has been contributing to the scientific discourse since 1980. With its ISSN 1040-8401 and E-ISSN 2162-6472, this journal provides a platform for critical analysis and comprehensive reviews that deepen understanding of immune responses and their implications in health and disease. Although currently categorized in the Q4 quartile for Immunology and Q3 for Immunology and Allergy, the journal's quality research and scholarly contributions are crucial for advancing knowledge within its fields—encompassing various aspects of innate and adaptive immunity. Researchers and professionals in immunology will find invaluable insights, aiding them in their quest for innovation and excellence, as the journal aims to foster interdisciplinary collaboration. While it does not operate on an open-access model, CRITICAL REVIEWS IN IMMUNOLOGY remains a significant resource for those dedicated to pushing the boundaries of immunology, with annual publications expected to last well into 2024 and beyond.
Immunotherapy
Transforming Disease Management Through ImmunotherapyImmunotherapy, published by Future Medicine Ltd, is a leading journal focused on the evolving field of immunotherapy within the realms of immunology, oncology, and allergy. With an ISSN of 1750-743X and an E-ISSN of 1750-7448, this academic journal has been at the forefront of groundbreaking research since 2009, and continues to illuminating insights in a landscape critical for the development of innovative therapeutic strategies through 2024. Positioned within Q2 and Q3 quartiles in various relevant categories, the journal ranks commendably in Scopus metrics, exhibiting robust engagement and relevance in Oncology and Immunology. It serves as an essential resource for researchers, clinicians, and students eager to stay abreast of advancements in immunotherapy, while also providing an open platform for sharing impactful studies. By disseminating high-quality research, Immunotherapy fosters a global dialogue among professionals and contributes significantly to the scientific community's collective knowledge on the increasing role of immune-based therapies in disease management.
CANCER IMMUNOLOGY IMMUNOTHERAPY
Transforming Insights into Effective Cancer TreatmentsCancer Immunology Immunotherapy, published by Springer, stands as a premier journal in the fields of cancer research and immunology, holding a prestigious Q1 ranking across multiple categories, including Oncology and Medicine as of 2023. With an ISSN of 0340-7004 and an E-ISSN of 1432-0851, this journal has been a pivotal platform for groundbreaking research since its inception in 1976, continuing to provide insight into the complex interactions between the immune system and cancer. The journal's scope encompasses a wide array of topics, including novel therapeutic strategies, immunological mechanisms, and translational science aimed at advancing treatment outcomes for cancer patients. Renowned for its rigorous peer-review process and high impact factor, it attracts contributions from leading experts and researchers around the globe, positioning itself among the top-tier publications with Scopus rankings that reflect its vital role in advancing the field. Access options are generally subscription-based, ensuring a comprehensive resource for professionals and academics seeking to deepen their understanding and make meaningful contributions to cancer immunotherapy.
Cellular & Molecular Immunology
Connecting Research, Practice, and Progress in ImmunologyCellular & Molecular Immunology is a prestigious peer-reviewed journal published by the CHIN SOCIETY IMMUNOLOGY. As a leading journal in the fields of immunology and infectious diseases, it proudly holds a Q1 designation across multiple categories, including Immunology, Allergy, and Medicine (Miscellaneous), reflecting its commitment to excellence and impactful research. With an ISSN of 1672-7681 and an E-ISSN of 2042-0226, the journal has been essential reading since its inception in 2004, continuously gathering insights from cutting-edge studies. It ranks impressively within Scopus, with positions in the 7th, 8th, and 9th percentile in relevant categories, establishing it as a cornerstone for researchers, clinicians, and students alike. The journal offers an extensive range of original research articles, reviews, and clinical studies, ensuring that readers stay at the forefront of immunological discovery. Whether you are interested in basic immunology, infectious diseases, or evolving therapies, Cellular & Molecular Immunology serves as an invaluable resource for advancing your knowledge and engagement in this dynamic field.
Trends in Cancer
Leading the Charge in Cutting-Edge Cancer DiscoveriesTrends in Cancer is a leading journal published by CELL PRESS, dedicated to advancing the field of cancer research and oncology. Since its inception in 2015, the journal has rapidly gained a reputation for excellence, securing both Q1 rankings in Cancer Research and Oncology categories for 2023 and boasting impressive Scopus ranks—#13 out of 404 in Medicine Oncology and #9 out of 230 in Biochemistry, Genetics and Molecular Biology, thus placing it in the top 4% of its field. The journal aims to publish high-quality, innovative research that offers new insights into cancer biology and treatment strategies. With a commitment to scholarly rigor and a broad scope that encompasses molecular mechanisms to therapeutic approaches, Trends in Cancer serves as an essential resource for researchers, professionals, and students eager to stay informed about the latest developments in cancer science. Although it is not an open-access journal, its contributions are pivotal in shaping the future of cancer research.
Cancer Communications
Transforming Cancer Research into Actionable KnowledgeCancer Communications, published by WILEY, is a leading open-access journal that has positioned itself at the forefront of cancer research and oncology since its inception in 2017. With an impressive HIndex reflective of its scholarly impact and recognized in the Q1 category for both Cancer Research and Oncology as of 2023, this journal consistently ranks in the top echelons of its field, specifically at Rank #16/404 and Rank #13/230 in their respective categories on Scopus. Cancer Communications aims to disseminate cutting-edge research findings, innovative methodologies, and significant advancements in cancer treatments, thereby fostering a deeper understanding of oncology among researchers, healthcare professionals, and students. The journal operates under an Open Access model since 2018, ensuring that vital research is accessible to a global audience, thus enhancing collaboration and knowledge sharing necessary to tackle one of the most pressing health challenges of our time. Located in Hoboken, NJ, United States, and with a strong commitment to scientific excellence, Cancer Communications remains an essential resource for anyone engaged in the fight against cancer.
HUMAN IMMUNOLOGY
Connecting Researchers in the Realm of ImmunologyHUMAN IMMUNOLOGY, published by Elsevier Science Inc, serves as a critical platform for disseminating research in the fields of immunology and allergy, as well as various aspects of miscellaneous medicine since its inception in 1980. With an ISSN of 0198-8859 and E-ISSN 1879-1166, this journal is pivotal for researchers and practitioners looking to advance their understanding of human immune responses and related conditions. The journal currently holds a respectable position within its field, as highlighted by its 2023 Scopus ranks—#114/233 in Immunology and Allergy and #132/236 in Immunology and Microbiology. Moreover, it maintains a Q2 quartile ranking in both Immunology and Allergy and miscellaneous Medicine, underscoring its influence and reach within the scientific community. Although it does not currently offer Open Access options, HUMAN IMMUNOLOGY remains dedicated to providing valuable insights and fostering academic discourse within its discipline, characterized by a rigorous peer-review process and a focus on innovative research trajectories.
GENES AND IMMUNITY
Pioneering Insights into Genetic Influences on ImmunityGENES AND IMMUNITY, published by SpringerNature, is a leading scholarly journal dedicated to advancing the field of genetics and immunology. With an impressive impact factor and a distinguished ranking in the Q1 quartile of both Genetics and Immunology disciplines for 2023, this journal serves as a pivotal platform for researchers and professionals looking to explore the intricate relationships between genetic factors and immune responses. Established in 1999 and continuously published until 2024, it features high-quality peer-reviewed research articles, reviews, and commentary that address critical issues and recent advancements in the field. The journal adheres to rigorous academic standards, evidenced by its strong Scopus rankings, making it a valuable resource for students, researchers, and practitioners alike who are seeking to deepen their understanding of genetics' role in immunity. For those looking to keep abreast of cutting-edge insights, GENES AND IMMUNITY is an essential read.